These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 88827

  • 1. [Use of anti-androgens in skin diseases].
    Nolting S.
    Z Hautkr; 1979 Jun 15; 54(12):529-32. PubMed ID: 88827
    [No Abstract] [Full Text] [Related]

  • 2. [Indications and limits of anti-androgen therapy].
    Zaun H.
    Z Hautkr; 1984 Aug 15; 59(16):1090-7. PubMed ID: 6207673
    [Abstract] [Full Text] [Related]

  • 3. [The effects of oral contraceptives on male-pattern alopecia, seborrhoea, acne vulgaris and hirsutism. Anamnestic study on 325 women].
    Hoffmann E, Meiers HG, Hubbes A.
    Dtsch Med Wochenschr; 1974 Oct 25; 99(43):2151-4, 2157. PubMed ID: 4139008
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment with the anti-androgens in the female].
    Kaiser E, Loch EG, Winckelmann G, Schröpl F, Dietz M, Hartmann P.
    Med Welt; 1976 Sep 24; 27(39):1836-41. PubMed ID: 135909
    [No Abstract] [Full Text] [Related]

  • 5. [Anti-androgen treatments in gynecology].
    Schindler AE.
    Dtsch Med Wochenschr; 1977 May 20; 102(20):763-5. PubMed ID: 67924
    [No Abstract] [Full Text] [Related]

  • 6. [Management of virilization with an antiandrogen-containing contraceptive].
    Apró G, Sas M.
    Orv Hetil; 1981 Jul 26; 122(30):1821-4. PubMed ID: 6458007
    [Abstract] [Full Text] [Related]

  • 7. [Experience in treating androgen-dependent diseases (androgenetic alopecia, acne agminata, hirsutism) with the preparation Diane].
    Rubina VV, Korchevaia TA, Kravchenko LIa.
    Vestn Dermatol Venerol; 1986 Jul 26; (7):21-5. PubMed ID: 2945335
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Anti-androgenic steroid cyproterone acetate. Clinical pharmacology and therapeutic use in hirsutism and acne].
    van Wayjen RG, van den Ende A.
    Ned Tijdschr Geneeskd; 1976 Jan 31; 120(5):189-95. PubMed ID: 129710
    [No Abstract] [Full Text] [Related]

  • 15. Acne vulgaris. The past. The present and the future.
    Cunliffe WJ.
    Acta Derm Venereol Suppl (Stockh); 1985 Jan 31; 120():34-8. PubMed ID: 2939675
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial.
    Plewig G, Cunliffe WJ, Binder N, Höschen K.
    Contraception; 2009 Jul 31; 80(1):25-33. PubMed ID: 19501212
    [Abstract] [Full Text] [Related]

  • 17. Clinical trial of cyproterone acetate-ethinyl oestradiol compound on androgen dependent skin disorders.
    Pai IF, Wu YC, Lu YC.
    Taiwan Yi Xue Hui Za Zhi; 1982 Aug 31; 81(8):1048-55. PubMed ID: 6217284
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Hirsutism treated with cyproterone acetate and ethinyl estradiol. Influence on androgens in the serum and urine and on urinary cortisol].
    Nielsen DR, Larsen J, Pedersen IM, Starup J.
    Ugeskr Laeger; 1985 Aug 12; 147(33):2589-93. PubMed ID: 2933857
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.